23.09.2008Pathworks Diagnostics closes $20m Financing

Press Release
28.08.2008Algeta Reports Positive Headline Phase II Data on Pain Palliation with Alpharadin

Press Release
14.08.2008SEP, the specialty urology company, closes a $15M series B financing

Press Release
12.03.2008Novel therapy for treatment of obesity enters clinical trials

Press Release
11.03.2008EUSA Pharma to Acquire US Specialty Oncology Company Cytogen

Press Release
25.02.2008Speciality European Pharma launches Plenaxis in Germany

Press Release
21.02.2008Algeta receives IND Approval for Alpharadin(TM) to commence Clinical Development in the USA

Press Release
18.02.2008EUSA Pharma out-licenses Preclinical-stage Human Antibody to GlaxoSmithKline for up to $44 million plus Royalities

Press Release
20.12.2007Algeta provides update on its late-stage clinical programme for Alpharadin in prostate cancer

Press Release
27.11.2007Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 with trial fully recruited and European and US Submission On Track for first half of 2008

Press Release